Georgios Karagkounis, MD
Colorectal Surgeon
My Role at MSKWe post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Areas of Expertise
My Specialties
- Colorectal Cancer
- Peritoneal Metastasis
- Peritoneal Surface Malignancies
About Me
- Assistant Attending Surgeon
As a cancer surgeon, I care for people with gastrointestinal and abdominal tumors, including:
- Colon cancer
- Rectal cancer
- Anal cancer
- Appendiceal cancer
- Peritoneal mesothelioma
In addition, I have a special interest in cancer that has spread within the abdominal cavity (known as “peritoneal metastasis” or “peritoneal carcinomatosis”). Although peritoneal metastasis is a late and serious manifestation of abdominal cancer, we have options to treat it.
Read more
I have expertise in performing cytoreductive surgery for people with peritoneal metastasis. We use this type of surgery to remove all of the cancer from the abdominal cavity. In appropriate cases, we give chemotherapy during the procedure (in the operating room) or during recovery; this treatment is called intraperitoneal chemotherapy. Cytoreductive surgery removes all visible cancer areas while the chemotherapy intends to kill any remaining microscopic ones that cannot be seen.
I also use minimally invasive surgical approaches whenever it is safe to do so. This includes laparoscopy and robotic surgery.
My decision to dedicate my life to cancer surgery, with an emphasis on colorectal cancer, comes from a family history of the disease. Seeing colorectal cancer affect my loved ones firsthand motivated me to make a difference in the lives of people with it. I was also inspired to focus on colorectal cancer because of how common it is. There is nothing more gratifying for me than being able to help people with cancer while trying to develop new and better ways to treat it.
Fortunately, colorectal cancer care is evolving rapidly and has changed tremendously in recent decades. We now have more treatment options than ever before, and in some cases, we can even activate a patient’s immune system to attack the cancer (immunotherapy). At the same time, the field of colorectal cancer is learning more about when we can safely spare patients other treatments that can be hard on the body, like radiation and surgery. These advancements hold promise for people with this disease.
Because colorectal cancer can require different types of treatments beyond surgery, I work closely with medical oncologists, radiation oncologists, and other experts at Memorial Sloan Kettering Cancer Center (MSK). We listen to what each of our patients wants and needs out of their care. Then, we create treatment plans that honor these preferences while getting them the best possible results.
Most of the people I see are still working through the anxiety and fear of a new cancer diagnosis. We all want to know what the future holds, and it is natural to look for long-term answers in times of stress. When I meet with patients, I emphasize the importance of taking everything one step and one decision at a time.
I also encourage my patients to talk openly about their concerns. I understand and respect that everyone deals with cancer differently, and I recognize that some of the worry that patients and their loved ones may feel is not about the diagnosis itself, but rather about another related stressor. We may have an easy solution for some of these concerns.
My research focuses on understanding why some tumors spread in the abdominal cavity while others do not, and how to treat the ones that do. I have a lab at MSK that focuses on learning about these mechanisms in colon and appendix cancer and developing new treatments for these diseases.
When I am not working, I enjoy traveling with my wife and two daughters and cherish our trips to see their grandparents in Europe. I also love watching and playing soccer, cooking (particularly Greek cuisine), and reading non-fiction books on history or mystery fiction novels.
A colorectal (KOH-loh-REK-tul) surgeon is a doctor with special training in surgery on the colon and rectum.
My Specialties
- Colorectal Cancer
- Peritoneal Metastasis
- Peritoneal Surface Malignancies
- Peritoneal Mesothelioma
- Colon Cancer
- Rectal Cancer
- Anal Cancer
- Appendeceal Cancer
- Cytoreductive Surgery
Education
- MD, University of Athens School of Medicine
Residencies
- General Surgery, Cleveland Clinic
Awards and Honors
- Society of Surgical Oncology Young Investigator Award (2022)
- "Steiger Award" for Significant Research Contribution, Cleveland Clinic (2019)
- Excellence in Teaching Award, Cleveland Clinic (2018, 2017, 2016)
- Research Forum Works in Progress Award, American Society of Colon & Rectal Surgeons (2017)
- Best Paper Award, American Society of Colon & Rectal Surgeons (2016)
- Career Development Award, Society of American Gastrointestinal & Endoscopic Surgeons (2015)
Fellowships
- Surgical Oncology Research, The Johns Hopkins University School of Medicine
- Colorectal Surgery Research, Cleveland Clinic
- Complex General Surgical Oncology, Memorial Sloan Kettering Cancer Center
Board Certifications
- Surgery
- Complex General Surgical Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
PPO, HMO, DSN
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO, POS, EPO, HMO
Offers a qualified health plan from the Health Insurance Marketplace. Call Emblem to learn more.
In Network Coverage Type
PPO, HMO
In Network Coverage Type
PPO
In Network Coverage Type
HMO, EPO
Offers a qualified health plan from the Health Insurance Marketplace. Call Fidelis to learn more.
In Network Coverage Type
EPO, HMO, PPO, POS
Offers a qualified health plan from the Health Insurance Marketplace. Call Healthfirst to learn more.
In Network Coverage Type
HMO
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment
Contact and Location
Dr. Karagkounis sees patients at three locations.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Karagkounis’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Georgios Karagkounis discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].